Vipul Gupta

Vipul Gupta

Auto-generated profile, based on publicly available information

Vipul Gupta

The Systems Biology Institute, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2016 in ACS Chemical Biology
Verified
Journal Article
Closed access
SKSusan Klaeger
Susan Klaeger
BGBjörn-Oliver Gohlke
Björn-Oliver Gohlke
JPJessica Perrin
Jessica Perrin
VGVipul Gupta
Vipul Gupta
SHStephanie Heinzlmeir
Stephanie Heinzlmeir
BKBernhard Kuster
Bernhard Kuster

20 December 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SCShuntaro Chiba
Shuntaro Chiba
Masahito OhueMasahito Ohue
Masahito Ohue
AGAnastasiia Gryniukova
Anastasiia Gryniukova
PBPetro Borysko
Petro Borysko
SZSergey Zozulya
Sergey Zozulya
MSMasakazu Sekijima
Masakazu Sekijima
Potential inhibitors of a target biomolecule, NAD-dependent deacetylase Sirtuin 1, were identified by a contest-based approach, in which participants were asked to propose a prioritized list of 400 compounds from a designated compound library containing 2.5 million compounds usingin silicomethods and scoring. Our aim was to identify target enzyme inhibitors and to benchmark computer-aided drug discovery methods under the same experimental conditions. Collecting compound lists derived from various methods is advantageous for aggregating compounds with structurally diversified properties compared with the use of a single method. The inhibitory action on Sirtuin 1 of approximately half of the proposed compounds was experimentally accessed. Ultimately, seven structurally diverse compounds were identified.

1 December 2013 in Molecular Pharmacology
Verified
Journal Article
Closed access
PDF file
VGVipul Gupta
Vipul Gupta
SLShujie Liu
Shujie Liu
HAHideki Ando
Hideki Ando
RIRyohei Ishii
Ryohei Ishii
STShumpei Tateno
Shumpei Tateno
HHHiroshi Handa
Hiroshi Handa
Salicylic acid is a classic nonsteroidal anti-inflammatory drug. Although salicylic acid also induces mitochondrial injury, the mechanism of its antimitochondrial activity is not well understood. In this study, by using a one-step affinity purification scheme with salicylic acid–immobilized beads, ferrochelatase (FECH), a homodimeric enzyme involved in heme biosynthesis in mitochondria, was identified as a new molecular target of salicylic acid. Moreover, the cocrystal structure of the FECH–salicylic acid complex was determined. Structural and biochemical studies showed that salicylic acid binds to the dimer interface of FECH in two possible orientations and inhibits its enzymatic activity. Mutational analysis confirmed that Trp301 and Leu311, hydrophobic amino acid residues located at the dimer interface, are directly involved in salicylic acid binding. On a gel filtration column, salicylic acid caused a shift in the elution profile of FECH, indicating that its conformational change is induced by salicylic acid binding. In cultured human cells, salicylic acid treatment or FECH knockdown inhibited heme synthesis, whereas salicylic acid did not exert its inhibitory effect in FECH knockdown cells. Concordantly, salicylic acid treatment or FECH knockdown inhibited heme synthesis in zebrafish embryos. Strikingly, the salicylic acid–induced effect in zebrafish was partially rescued by FECH overexpression. Taken together, these findings illustrate that FECH is responsible for salicylic acid–induced inhibition of heme synthesis, which may contribute to its antimitochondrial and anti-inflammatory function. This study establishes a novel aspect of the complex pharmacological effects of salicylic acid.

5 June 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HNHaruhiko Nakamura
Haruhiko Nakamura
KFKiyonaga Fujii
Kiyonaga Fujii
VGVipul Gupta
Vipul Gupta
HHHiroko Hata
Hiroko Hata
HKHirotaka Koizumu
Hirotaka Koizumu
TNToshihide Nishimura
Toshihide Nishimura
Small-cell lung carcinoma (SCLC) and large-cell neuroendocrine lung carcinoma (LCNEC) are high-grade lung neuroendocrine tumors (NET). However, comparative protein expression within SCLC and LCNEC remains unclear. Here, protein expression profiles were obtained via mass spectrometry-based proteomic analysis. Weighted gene co-expression network analysis (WGCNA) identified co-expressed modules and hub genes. Of 34 identified modules, six were significant and selected for protein–protein interaction (PPI) network analysis and pathway enrichment. Within the six modules, the activation of cellular processes and complexes, such as alternative mRNA splicing, translation initiation, nucleosome remodeling and deacetylase (NuRD) complex, SWItch/Sucrose Non-Fermentable (SWI/SNF) superfamily-type complex, chromatin remodeling pathway, and mRNA metabolic processes, were significant to SCLC. Modules enriched in processes, including signal recognition particle (SRP)-dependent co-translational protein targeting to membrane, nuclear-transcribed mRNA catabolic process of nonsense-mediated decay (NMD), and cellular macromolecule catabolic process, were characteristically activated in LCNEC. Novel high-degree hub genes were identified for each module. Master and upstream regulators were predicted via causal network analysis. This study provides an understanding of the molecular differences in tumorigenesis and malignancy between SCLC and LCNEC and may help identify potential therapeutic targets.

23 April 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
KBKonstantin Barylyuk
Konstantin Barylyuk
LKLudek Koreny
Ludek Koreny
HKHuiling Ke
Huiling Ke
SBSimon Butterworth
Simon Butterworth
OCOliver M. Crook
Oliver M. Crook
Ross WallerRoss Waller
Ross Waller
Apicomplexan parasites cause major human disease and food insecurity. They owe their considerable success to novel, highly specialized cell compartments and structures. These adaptations drive their recognition and non-destructive penetration of host’s cells and the elaborate reengineering of these cells to promote growth, dissemination, and the countering of host defenses. The evolution of unique apicomplexan cellular compartments is concomitant with vast proteomic novelty that defines these new cell organizations and their functions. Consequently, half of apicomplexan proteins are unique and uncharacterized, and these cells are, therefore, very poorly understood. Here, we determine the steady-state subcellular location of thousands of proteins simultaneously within the globally prevalent apicomplexan parasite Toxoplasma gondii . This provides unprecedented comprehensive molecular definition to these cells and their novel compartments, and these data reveal the spatial organizations of protein expression and function, adaptation to hosts, and the underlying evolutionary trajectories of these pathogens.

20 November 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ABArchana Bajpai
Archana Bajpai
TITakashi Ishii
Takashi Ishii
KMKosuke Miyauchi
Kosuke Miyauchi
VGVipul Gupta
Vipul Gupta
YNYuka Nishio-Masaike
Yuka Nishio-Masaike
HKHiroaki Kitano
Hiroaki Kitano
Specific deletion of suppressor of cytokine signaling 3 (Socs3) in keratinocytes can cause severe skin inflammation with infiltration of immune cells. The molecular mechanisms and key regulatory pathways involved in these processes remain elusive. To investigate the role of Socs3 in keratinocytes, we generated and analyzed global RNA-Seq profiles from Socs3 conditional knockout (cKO) mice of two different ages (2 and 10 weeks). Over 400 genes were significantly regulated at both time points. Samples from 2-week-old mice exhibited down-regulation of genes involved in keratin-related functions and up-regulation of genes involved in lipid metabolism. At week 10, multiple chemokine and cytokine genes were up-regulated. Functional annotation revealed that the genes differentially expressed in the 2-week-old mice play roles in keratinization, keratinocyte differentiation, and epidermal cell differentiation. By contrast, differentially expressed genes in the 10-week-old animals are involved in acute immune-related functions. A group of activator protein-1–related genes were highly up-regulated in Socs3 cKO mice of both ages. This observation was validated using qRT-PCR by SOCS3-depleted human keratinocyte–derived HaCaT cells. Our results suggest that, in addition to participating in immune-mediated pathways, SOCS3 also plays important roles in skin barrier homeostasis.